These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37409000)

  • 41. Intranasal Azelastine and Fluticasone as Combination Therapy for Allergic Rhinitis: Systematic Review and Meta-analysis.
    Debbaneh PM; Bareiss AK; Wise SK; McCoul ED
    Otolaryngol Head Neck Surg; 2019 Sep; 161(3):412-418. PubMed ID: 30961435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioequivalence and pharmacokinetic comparison of two mycophenolate mofetil formulations in healthy Chinese male volunteers: an open-label, randomized-sequence, single-dose, two-way crossover study.
    Zhang Q; Tao Y; Zhu Y; Zhu D
    Clin Ther; 2010 Jan; 32(1):171-8. PubMed ID: 20171422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitis.
    Davis GA; Rudy AC; Archer SM; Wermeling DP; McNamara PJ
    Pharmacotherapy; 2004 Jan; 24(1):26-32. PubMed ID: 14740785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Burden of allergic rhinitis and impact of MP-AzeFlu from the patient perspective: pan European patient survey.
    Canonica GW; Klimek L; Acaster S; Dollner R; Kaulsay R; Lo SH; Price DB; Scadding GK; Valovirta E; Zieglmayer P
    Curr Med Res Opin; 2021 Jul; 37(7):1259-1272. PubMed ID: 33840316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Superior effect of MP-AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP-1 and TTP anti-inflammatory gene expression in healthy and inflamed upper airway mucosa.
    Vicens-Artés S; Roca-Ferrer J; Tubita V; Fuentes M; Alobid I; Valero A; Kopietz F; Nguyen D; Mullol J
    Clin Exp Allergy; 2022 Jun; 52(6):788-791. PubMed ID: 35066955
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/probenecid (333 mg): a randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteers.
    Wu H; Liu M; Wang S; Feng W; Yao W; Zhao H; Wei M
    Clin Ther; 2010 Mar; 32(3):597-606. PubMed ID: 20399996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Romania.
    Agache I; Doros IC; Leru PM; Bucur I; Poenaru M; Sarafoleanu C
    Rhinology; 2018 Mar; 56(1):33-41. PubMed ID: 28942457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of intranasal mometasone in the fixed-dose combination GSP301 versus two monotherapy intranasal mometasone formulations.
    Patel P; Salapatek AM; Talluri RS; Tantry SK
    Allergy Asthma Proc; 2018 May; 39(3):232-239. PubMed ID: 29669668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative Bioavailability and Tolerability of a Single 2-mg Dose of 2 Repaglinide Tablet Formulations in Fasting, Healthy Chinese Male Volunteers: An Open-Label, Randomized-Sequence, 2-Period Crossover Study.
    Zhai XJ; Hu K; Chen F; Lu YN
    Curr Ther Res Clin Exp; 2013 Dec; 75():48-52. PubMed ID: 24465043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis.
    Wolthers OD
    Recent Pat Inflamm Allergy Drug Discov; 2013 Sep; 7(3):223-8. PubMed ID: 23862774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers.
    Galán-Herrera JF; Poo JL; Maya-Barrios JA; de Lago A; Oliva I; González-de la Parra M; Jiménez P; López-Bojórquez E; Burke-Fraga V; Namur S
    Clin Ther; 2008 Sep; 30(9):1667-74. PubMed ID: 18840372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers: an open-label, randomized-sequence, two-period crossover study.
    Shi S; Liu Y; Wu J; Li Z; Zhao Y; Zhong D; Zeng F
    Clin Ther; 2010 Oct; 32(11):1977-86. PubMed ID: 21095492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
    Sun F; Liu Y; Li T; Lin P; Jiang X; Li X; Wang C; Gao X; Ma Y; Fu Y; Cao Y
    BMC Pharmacol Toxicol; 2023 Feb; 24(1):7. PubMed ID: 36737825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics and bioequivalence evaluation of two losartan potassium 50-mg tablets: A single-dose, randomized-sequence, open-label, two-way crossover study in healthy Chinese male volunteers.
    Jia JY; Zhang MQ; Liu YM; Liu Y; Liu GY; Li SJ; Lu C; Weng LP; Qi YL; Yu C
    Clin Ther; 2010 Jul; 32(7):1387-95. PubMed ID: 20678685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative fasting bioavailability and pharmacokinetic properties of 2 formulations of glucosamine hydrochloride in healthy Chinese adult male volunteers.
    Wu H; Liu M; Wang S; Zhao H; Yao W; Feng W; Yan M; Tang Y; Wei M
    Arzneimittelforschung; 2012 Aug; 62(8):367-71. PubMed ID: 22791244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioequivalence of two oseltamivir formulations in healthy Chinese volunteers
.
    Yun YL; Gao SH; Wen Y; Wang ZP; Miao HJ; Chen WS
    Int J Clin Pharmacol Ther; 2017 Sep; 55(9):761-768. PubMed ID: 28737128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Celecoxib-tramadol co-crystal: A Randomized 4-Way Crossover Comparative Bioavailability Study.
    Cebrecos J; Carlson JD; Encina G; Lahjou M; Sans A; Sust M; Vaqué A; Morte A; Gascón N; Plata-Salamán C
    Clin Ther; 2021 Jun; 43(6):1051-1065. PubMed ID: 34167827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics and Bioequivalence of Two Formulations of Febuxostat 40-Mg and 80-Mg Tablets: A Randomized, Open-Label, 4-Way Crossover Study in Healthy Chinese Male Volunteers.
    Luo Z; Nan F; Miao J; Chen Z; Li M; Liang M
    PLoS One; 2016; 11(3):e0150661. PubMed ID: 26974539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetic and bioequivalence comparison of a single 100-mg dose of cefteram pivoxil powder suspension and tablet formulations: a randomized-sequence, open-label, two-period crossover study in healthy Chinese adult male volunteers.
    Zou J; Di B; Wu CY; Hu Q; Li JH; Zhu Y; Fan H; Xiao D; Wang GJ
    Clin Ther; 2008 Apr; 30(4):654-60. PubMed ID: 18498914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.